Clinical observation on effect of yangxue qingnao granule in treating patients with cerebral arteriosclerosis / 中国中西医结合杂志
Chinese Journal of Integrated Traditional and Western Medicine
; (12): 202-204, 2004.
Article
en Zh
| WPRIM
| ID: wpr-320213
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the efficacy of Yangxue Qingnao granule (YXQN) in treating cerebral arteriosclerosis and to explore its mechanisms.</p><p><b>METHODS</b>One hundred and sixty-seven patients with arteriosclerosis were randomly divided into the treated group treated with conventional medical treatment plus YXQN and the control group treated with conventional medical treatment alone, to observe the changes before and after treatment in scores of chief symptoms, mean velocity of cerebral blood flow (VM), plasma nitric oxide (NO), calcitonin gene related peptide (CGRP) and endothelin (ET) levels.</p><p><b>RESULTS</b>(1) After treatment in treated group, the scores of chief symptoms such as vertigo, headache and tinnitus were significantly lower than those in the control group (P < 0.05 or P < 0.01); (2) NO and CGRP level in the treated group after treatment obviously elevated, and ET and VM markedly reduced (P < 0.01), while no evident change of these parameters was found in the control group (P < 0.01).</p><p><b>CONCLUSION</b>The efficacy of YXQN in treating cerebral arteriosclerosis is definite, modulating the level of vasoactive factors was its important mechanism.</p>
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Sangre
/
Velocidad del Flujo Sanguíneo
/
Medicamentos Herbarios Chinos
/
Péptido Relacionado con Gen de Calcitonina
/
Arterias Cerebrales
/
Arteriosclerosis Intracraneal
/
Endotelinas
/
Usos Terapéuticos
/
Quimioterapia
/
Fitoterapia
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
Zh
Revista:
Chinese Journal of Integrated Traditional and Western Medicine
Año:
2004
Tipo del documento:
Article